Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S159-p
ERK1 S623-p
JAK2 Y643-p
ZAP70 Y614-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S159-p
ERK1 S623-p
ERK2 S623-p
JAK2 Y643-p
Regulatory protein:
EPOR Y476-p , Y614-p , Y643-p
PIK3CA S210-p , T391-p
TSLP S159-p
ZAP70 Y266-p
Treatment:
AG490 Y643-p
Akt-I-1,2 S210-p , T391-p
angiotensin_2 S543-p
dasatinib Y643-p
EGF S133-p , S140-p , S141-p , S148-p , S149-p , S159-p , S210-p , S223-p , S264-p , S281-p , T287-p , Y293-p , T331-p , T391-p , S543-p , S622-p , S623-p
Epo Y476-p , Y614-p , Y643-p
FGF2 Y293-p , Y409-p
G-CSF Y643-p
Go_6850 S210-p , T391-p
Go_6976 S210-p , T391-p
H-89 S210-p , T391-p
heregulin S159-p
IL-2 S285-p , Y293-p , S368-p , T391-p , S543-p , Y614-p , Y643-p
insulin S210-p , T391-p
ischemia S543-p
KN-62 S210-p , T391-p
LY294002 S210-p , T391-p
metastatic potential S141-p
mPKI S210-p , T391-p
rapamycin S210-p , T391-p
selumetinib S543-p
SII_angiotensin_2 S543-p
U0126 S210-p , T391-p
vemurafenib S543-p
wortmannin S210-p , T391-p
Y27632 S210-p , T391-p , T546-p